Skip to main content

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in DNLI — Denali Therapeutics Inc.

CIK 1086619 London, X0

Position in DNLI

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$5,487,743
-$1,958,018 QoQ
Shares Held
285,820
-36.6% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,487,743 285,820
2025-12-31 $7,445,761 450,985
2025-09-30 $3,043,319 209,595
2025-06-30 $5,407,680 386,539
2025-03-31 $3,966,953 291,795
2024-12-31 $5,050,164 247,800
2024-09-30 $3,708,423 127,306
2024-06-30 $8,019,561 345,373
2023-12-31 $3,304,840 154,000